nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—Purine salvage—APRT—nephrolithiasis	0.235	0.332	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—APRT—nephrolithiasis	0.112	0.158	CbGpPWpGaD
Nelarabine—ADA—Purine salvage—APRT—nephrolithiasis	0.078	0.11	CbGpPWpGaD
Nelarabine—DCK—Purine salvage—APRT—nephrolithiasis	0.072	0.102	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—APRT—nephrolithiasis	0.056	0.0791	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—APRT—nephrolithiasis	0.037	0.0523	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—APRT—nephrolithiasis	0.0342	0.0483	CbGpPWpGaD
Nelarabine—Adenosine monophosphate—APRT—nephrolithiasis	0.0217	1	CrCbGaD
Nelarabine—ADA—Nucleotide metabolism—APRT—nephrolithiasis	0.0186	0.0263	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—APRT—nephrolithiasis	0.0172	0.0242	CbGpPWpGaD
Nelarabine—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0522	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0487	CcSEcCtD
Nelarabine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.01	0.0387	CcSEcCtD
Nelarabine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00982	0.0379	CcSEcCtD
Nelarabine—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0361	CcSEcCtD
Nelarabine—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0341	CcSEcCtD
Nelarabine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0341	CcSEcCtD
Nelarabine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00843	0.0325	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GRHPR—nephrolithiasis	0.00672	0.00949	CbGpPWpGaD
Nelarabine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0063	0.0243	CcSEcCtD
Nelarabine—DGUOK—Metabolism—AGXT—nephrolithiasis	0.00599	0.00846	CbGpPWpGaD
Nelarabine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00593	0.0229	CcSEcCtD
Nelarabine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00591	0.0228	CcSEcCtD
Nelarabine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00574	0.0221	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0219	CcSEcCtD
Nelarabine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00556	0.0215	CcSEcCtD
Nelarabine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00549	0.0212	CcSEcCtD
Nelarabine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0051	0.0197	CcSEcCtD
Nelarabine—DGUOK—Metabolism—SLC26A1—nephrolithiasis	0.00509	0.00719	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APRT—nephrolithiasis	0.00509	0.00719	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00492	0.019	CcSEcCtD
Nelarabine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00489	0.0189	CcSEcCtD
Nelarabine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0184	CcSEcCtD
Nelarabine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0177	CcSEcCtD
Nelarabine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00456	0.0176	CcSEcCtD
Nelarabine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00434	0.0167	CcSEcCtD
Nelarabine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0166	CcSEcCtD
Nelarabine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00372	0.0143	CcSEcCtD
Nelarabine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00367	0.0142	CcSEcCtD
Nelarabine—DGUOK—Metabolism—AQP1—nephrolithiasis	0.00363	0.00512	CbGpPWpGaD
Nelarabine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00358	0.0138	CcSEcCtD
Nelarabine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00356	0.0137	CcSEcCtD
Nelarabine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00351	0.0135	CcSEcCtD
Nelarabine—DGUOK—renal system—nephrolithiasis	0.00341	0.304	CbGeAlD
Nelarabine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.0131	CcSEcCtD
Nelarabine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00334	0.0129	CcSEcCtD
Nelarabine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00331	0.0128	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CHRM3—nephrolithiasis	0.00328	0.00463	CbGpPWpGaD
Nelarabine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0125	CcSEcCtD
Nelarabine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0125	CcSEcCtD
Nelarabine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0125	CcSEcCtD
Nelarabine—DGUOK—cortex of kidney—nephrolithiasis	0.00321	0.286	CbGeAlD
Nelarabine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0121	CcSEcCtD
Nelarabine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0031	0.012	CcSEcCtD
Nelarabine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00303	0.0117	CcSEcCtD
Nelarabine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00295	0.0114	CcSEcCtD
Nelarabine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0112	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0109	CcSEcCtD
Nelarabine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0028	0.0108	CcSEcCtD
Nelarabine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00278	0.0107	CcSEcCtD
Nelarabine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00276	0.0107	CcSEcCtD
Nelarabine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00275	0.0106	CcSEcCtD
Nelarabine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00269	0.0104	CcSEcCtD
Nelarabine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00267	0.0103	CcSEcCtD
Nelarabine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00265	0.0102	CcSEcCtD
Nelarabine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00265	0.0102	CcSEcCtD
Nelarabine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00985	CcSEcCtD
Nelarabine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00978	CcSEcCtD
Nelarabine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00945	CcSEcCtD
Nelarabine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00945	CcSEcCtD
Nelarabine—ADA—Metabolism—GRHPR—nephrolithiasis	0.00223	0.00315	CbGpPWpGaD
Nelarabine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00858	CcSEcCtD
Nelarabine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00818	CcSEcCtD
Nelarabine—DCK—Metabolism—GRHPR—nephrolithiasis	0.00206	0.00291	CbGpPWpGaD
Nelarabine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00791	CcSEcCtD
Nelarabine—ADA—Metabolism—AGXT—nephrolithiasis	0.00199	0.00281	CbGpPWpGaD
Nelarabine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00197	0.0076	CcSEcCtD
Nelarabine—ADA—renal system—nephrolithiasis	0.00195	0.174	CbGeAlD
Nelarabine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00749	CcSEcCtD
Nelarabine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00184	0.0071	CcSEcCtD
Nelarabine—DCK—Metabolism—AGXT—nephrolithiasis	0.00183	0.00259	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APRT—nephrolithiasis	0.00169	0.00239	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC26A1—nephrolithiasis	0.00169	0.00239	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APRT—nephrolithiasis	0.00156	0.0022	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC26A1—nephrolithiasis	0.00156	0.0022	CbGpPWpGaD
Nelarabine—DCK—nephron tubule—nephrolithiasis	0.00143	0.127	CbGeAlD
Nelarabine—DCK—cortex of kidney—nephrolithiasis	0.00122	0.109	CbGeAlD
Nelarabine—ADA—Metabolism—AQP1—nephrolithiasis	0.0012	0.0017	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AQP1—nephrolithiasis	0.00111	0.00157	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CHRM3—nephrolithiasis	0.00109	0.00154	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CHRM3—nephrolithiasis	0.001	0.00142	CbGpPWpGaD
